Company or ticker...

Roivant Sciences

Roivant builds and funds biotech companies around drug programs.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ROIV

24.5B

2,966.8

n/a

56.93%

Key Facts

M. Cap

PS

PE

YTD

24.5B

2,966.8

n/a

56.93%

10MA

20MA

50MA

200MA

$ROIV